Year All2026202520242023202220212020 Jul 14, 2026 Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants PDF Version Jul 13, 2026 Q32 Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants PDF Version Jul 13, 2026 Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata PDF Version Jul 10, 2026 Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026 PDF Version May 27, 2026 Q32 Bio Announces $55 Million Private Placement Financing PDF Version May 05, 2026 Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update PDF Version Apr 08, 2026 Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare Conference PDF Version Mar 10, 2026 Q32 Bio Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update PDF Version Feb 18, 2026 Q32 Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference PDF Version Feb 17, 2026 Q32 Bio Announces $10.5 Million Registered Direct Offering PDF Version
Jul 14, 2026 Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants PDF Version
Jul 13, 2026 Q32 Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants PDF Version
Jul 13, 2026 Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata PDF Version
Jul 10, 2026 Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026 PDF Version
May 05, 2026 Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update PDF Version
Apr 08, 2026 Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare Conference PDF Version
Mar 10, 2026 Q32 Bio Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update PDF Version
Feb 18, 2026 Q32 Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference PDF Version